Literature DB >> 19883249

Drug delivery technologies for chronotherapeutic applications.

Zaheeda Khan1, Viness Pillay, Yahya E Choonara, Lisa C du Toit.   

Abstract

It has been proven that the body follows a 24-hour cycle called a circadian rhythm. This cycle is coordinated by the suprachiasmatic nucleus and controls nearly all bodily functions including those related to drug delivery. Knowledge of the body's circadian rhythm leads to an improved understanding of diseases and their treatment, known as chronotherapy, such that synchronizing drug application in accordance with the natural rhythm of the body leads to improved disease management and a greater patient therapeutic outcome. Chronotherapeutic diseases include asthma, cardiovascular diseases, glaucoma, rheumatoid arthritis and cancers. In order to treat these diseases numerous chronotherapeutic drug delivery systems have been developed, such that drug is released in the period when it is most needed. This review paper attempts to concisely explicate the role of circadian rhythms in various disease states and furthermore describes the various oral drug delivery technologies that have been employed for the treatment of chronotherapeutic diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19883249     DOI: 10.3109/10837450902922736

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  12 in total

Review 1.  Chronopharmaceutical drug delivery systems: Hurdles, hype or hope?

Authors:  Bi-Botti C Youan
Journal:  Adv Drug Deliv Rev       Date:  2010-05-12       Impact factor: 15.470

Review 2.  Systems Chronotherapeutics.

Authors:  Annabelle Ballesta; Pasquale F Innominato; Robert Dallmann; David A Rand; Francis A Lévi
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 3.  The circadian clock in cancer development and therapy.

Authors:  Loning Fu; Nicole M Kettner
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

4.  Chronotherapeutic Drug Delivery of Ketoprofen and Ibuprofen for Improved Treatment of Early Morning Stiffness in Arthritis Using Hot-Melt Extrusion Technology.

Authors:  Nagi Reddy Dumpa; Sandeep Sarabu; Suresh Bandari; Feng Zhang; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2018-07-02       Impact factor: 3.246

5.  Pharmacokinetics-Based Chronoefficacy of Semen Strychni and Tripterygium Glycoside Tablet Against Rheumatoid Arthritis.

Authors:  Jingpan Lin; Lu Gao; Yanke Lin; Shuai Wang; Zemin Yang; Shujing Ren; Min Chen; Baojian Wu
Journal:  Front Pharmacol       Date:  2021-05-24       Impact factor: 5.810

6.  Drug Delivery: Enabling Technology for Drug Discovery and Development. iPRECIO Micro Infusion Pump: Programmable, Refillable, and Implantable.

Authors:  Tsung Tan; Stephanie W Watts; Robert Patrick Davis
Journal:  Front Pharmacol       Date:  2011-07-29       Impact factor: 5.810

7.  Gastroretentive pulsatile release tablets of lercanidipine HCl: development, statistical optimization, and in vitro and in vivo evaluation.

Authors:  Gagganapalli Santhoshi Reddy; Usha Yogendra Nayak; Praful Balavant Deshpande; Srinivas Mutalik
Journal:  ScientificWorldJournal       Date:  2014-11-26

Review 8.  Timing of Administration: For Commonly-Prescribed Medicines in Australia.

Authors:  Gagandeep Kaur; Craig L Phillips; Keith Wong; Andrew J McLachlan; Bandana Saini
Journal:  Pharmaceutics       Date:  2016-04-15       Impact factor: 6.321

9.  Pulsatile Drug Delivery System Triggered by Acoustic Radiation Force.

Authors:  Sabrina Ciancia; Andrea Cafarelli; Anna Zahoranova; Arianna Menciassi; Leonardo Ricotti
Journal:  Front Bioeng Biotechnol       Date:  2020-04-17

10.  Circadian Effects of Drug Responses.

Authors:  Yaakov Nahmias; Ioannis P Androulakis
Journal:  Annu Rev Biomed Eng       Date:  2021-03-31       Impact factor: 9.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.